Published in J Cancer Res Clin Oncol on March 19, 2017
Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology (1988) 8.08
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia (2009) 7.44
Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst (2007) 7.10
Predictive value of intratumoral 99mTc-macroaggregated albumin uptake in patients with colorectal liver metastases scheduled for radioembolization with 90Y-microspheres. J Nucl Med (2013) 4.69
Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging (2006) 1.91
Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology (2008) 1.85
Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis. Eur Radiol (2008) 1.69
Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer (2002) 1.65
Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. J Clin Oncol (2010) 1.61
Apparent diffusion coefficient: a quantitative parameter for in vivo tumor characterization. Eur J Radiol (2003) 1.50
Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw (2013) 1.17
Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness. J Magn Reson Imaging (2012) 1.13
Early evaluation of cancer response by a new functional biomarker: apparent diffusion coefficient. AJR Am J Roentgenol (2011) 1.06
Radioembolization of liver tumors with yttrium-90 microspheres. Semin Nucl Med (2010) 1.06
T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging. Radiology (2009) 1.05
Yttrium-90 radioembolization for liver malignancies: prognostic factors associated with survival. J Vasc Interv Radiol (2009) 0.98
The role of functional imaging in colorectal cancer. AJR Am J Roentgenol (2010) 0.93
Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy. Eur J Nucl Med Mol Imaging (2014) 0.91
Metachronous metastases from colorectal cancer: a population-based study in North-East Netherlands. Int J Colorectal Dis (2014) 0.89
The role of pre-treatment diffusion-weighted MRI in predicting long-term outcome of colorectal liver metastasis. Br J Radiol (2013) 0.88
Prognostic Role of Diffusion-weighted MR Imaging for Resectable Gastric Cancer. Radiology (2015) 0.85
Multimodality imaging to predict response to systemic treatment in patients with advanced colorectal cancer. PLoS One (2015) 0.84
Increased tumour ADC value during chemotherapy predicts improved survival in unresectable pancreatic cancer. Eur Radiol (2015) 0.82
Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy. J Magn Reson Imaging (2016) 0.82
Diffusion-weighted imaging with acquisition of three b-values for response evaluation of neuroendocrine liver metastases undergoing selective internal radiotherapy. Eur Radiol (2013) 0.81
Residual low ADC and high FA at the resection margin correlate with poor chemoradiation response and overall survival in high-grade glioma patients. Eur J Radiol (2015) 0.80
Outcomes of Therasphere Radioembolization for Colorectal Metastases. Clin Colorectal Cancer (2015) 0.78
Robust evidence for long-term survival with (90)Y radioembolization in chemorefractory liver-predominant metastatic colorectal cancer. Eur Radiol (2016) 0.78
Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases. Eur Radiol (2015) 0.78
Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study. J Magn Reson Imaging (2015) 0.77
The efficacy of chemotherapy in patients with high-grade metastatic colon cancer. Hepatogastroenterology (2011) 0.77
Diagnostic accuracy of diffusion-weighted magnetic resonance imaging versus positron emission tomography/computed tomography for early response assessment of liver metastases to Y90-radioembolization. Invest Radiol (2015) 0.77
Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapy. Eur Radiol (2016) 0.77
Pattern of tumour growth of the primary colon cancer predicts long-term outcome after resection of liver metastases. Scand J Gastroenterol (2016) 0.76